The growing gap between what the public had been told R&D costs are, and the...
One of the reasons why drug companies have fought so hard to block transparency of clinical trial costs is the growing gap between what the public had been told those costs are, and the actual costs,...
View ArticleCBO score of HR 3 has an interesting estimate of the trade-off between the...
On October 11, 2019, the U.S. Congressional Budget Office (CBO) sent a letter to Representative Frank Pallone Jr., Chairman of the Committee on Energy and Commerce, describing a preliminary estimate of...
View ArticleWTO TRIPS Council (October 2019): Statement of South Africa on the...
On Friday, 18 October 2019, South Africa delivered the following statement at the WTO TRIPS Council on transparency of R&D Costs and Pricing of Medicines and Health Technology. Intellectual...
View ArticleKEI comments on DRAFT NIH Policy for Data Management and Sharing and...
KEI filed these comments on the NIH Draft Policy for Data Management and Sharing and Supplemental DRAFT Guidance January 10, 2019 1621 Connecticut Avenue NW Suite 500 Washington, DC 20009...
View ArticleWIPO General Assembly (May 2020): KEI statement on the appointment of Daren...
The World Intellectual Property Organization (WIPO) is convening an extraordinary session of the WIPO General Assembly from May 7, 2020 to May 8, 2020; the purpose of this extraordinary session of the...
View ArticleWHA73: Written statement of KEI – Agenda item 3 – Address by WHO...
KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6...
View ArticleWhat is a Global Public Good?
Below is a link to an essay on the use of the phrase “global public goods”. The essay focuses on the three papers Paul Samuelson wrote in the 1950s that are often used, and misused, to define public...
View ArticleResearch Mandates
KEI Research Note: 2020-4: The current and potential role of biomedical research mandates 2020 The current and potential role of biomedical research mandates. Progress in biomedical research depends...
View ArticleGeneral Statement of Knowledge Ecology International – Sixty-First Series of...
General Statement of Knowledge Ecology International – Sixty-First Series of Meetings of the Assemblies of the Member States of WIPO (WIPO Assemblies) Agenda item 5 – General Statements 21 September...
View ArticleEB 148: KEI’s statement on WHO’s Global Observatory on Health R&D
On Friday, 22 January 2021, Knowledge Ecology International delivered the following remarks on WHO”s Global Observatory on Health R&D at the 148th session of WHO’s Executive Board. At meetings of...
View Article
